GeneMatrix Inc (109820) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.027x

Based on the latest financial reports, GeneMatrix Inc (109820) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩500.19 Million ≈ $338.97K USD) by net assets (₩18.32 Billion ≈ $12.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GeneMatrix Inc (109820) total market value for the company's overall valuation and market capitalisation.

GeneMatrix Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how GeneMatrix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GeneMatrix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GeneMatrix Inc ranked by their cash flow conversion efficiency. Explore GeneMatrix Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
PODIUM MINERALS F:55D	N/A
Diamond Citra Propertindo PT JK:DADA	0.018x
Pivotree Inc V:PVT	0.002x
Eagon Ind KO:008250	0.033x
Blue Star Helium Ltd AU:BNL	-0.252x
Eastparc Hotel Tbk PT JK:EAST	0.017x
Victor Group Holdings Ltd AU:VIG	0.072x
Cubic Korea Inc KQ:021650	-0.024x

Annual Cash Flow Conversion Efficiency for GeneMatrix Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of GeneMatrix Inc from 2014 to 2024. View GeneMatrix Inc (109820) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩19.23 Billion ≈ $13.03 Million	₩-200.12 Million ≈ $-135.62K	-0.010x	+89.73%
2023-12-31	₩23.15 Billion ≈ $15.69 Million	₩-2.35 Billion ≈ $-1.59 Million	-0.101x	-139.49%
2022-12-31	₩24.19 Billion ≈ $16.39 Million	₩-1.02 Billion ≈ $-693.53K	-0.042x	-140.59%
2021-12-31	₩32.32 Billion ≈ $21.90 Million	₩3.37 Billion ≈ $2.28 Million	0.104x	-22.75%
2020-12-31	₩33.39 Billion ≈ $22.63 Million	₩4.51 Billion ≈ $3.05 Million	0.135x	+190.33%
2019-12-31	₩15.25 Billion ≈ $10.33 Million	₩-2.28 Billion ≈ $-1.54 Million	-0.149x	+40.89%
2018-12-31	₩10.83 Billion ≈ $7.34 Million	₩-2.74 Billion ≈ $-1.86 Million	-0.253x	-57.59%
2017-12-31	₩11.06 Billion ≈ $7.49 Million	₩-1.77 Billion ≈ $-1.20 Million	-0.160x	-436.38%
2016-12-31	₩12.48 Billion ≈ $8.46 Million	₩-373.25 Million ≈ $-252.95K	-0.030x	+49.30%
2015-12-31	₩10.04 Billion ≈ $6.80 Million	₩-591.96 Million ≈ $-401.17K	-0.059x	+49.01%
2014-12-31	₩11.89 Billion ≈ $8.06 Million	₩-1.38 Billion ≈ $-931.91K	-0.116x	--

About GeneMatrix Inc

KQ:109820 Korea Diagnostics & Research

Market Cap

$21.77 Million

₩32.12 Billion KRW

Market Cap Rank

#24912 Global

#1800 in Korea

Share Price

₩1609.00

Change (1 day)

+0.56%

52-Week Range

₩1314.00 - ₩3245.00

All Time High

₩33900.00